15 related articles for article (PubMed ID: 3732454)
1. Base editing in humanized dystrophic mice.
Zhang C; Zhou Y; Han R
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102185. PubMed ID: 38638582
[No Abstract] [Full Text] [Related]
2. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice.
Komatsu K; Inazuki K; Hosoya J; Satoh S
Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877
[TBL] [Abstract][Full Text] [Related]
3. Chymostatin has no apparent beneficial effect on muscular dystrophy in the mdx mouse.
Christie KN
J Neurol Sci; 1988 Apr; 84(2-3):341-6. PubMed ID: 3379449
[TBL] [Abstract][Full Text] [Related]
4. Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle.
Libby P; Goldberg AL
Biochem J; 1980 Apr; 188(1):213-20. PubMed ID: 7406880
[TBL] [Abstract][Full Text] [Related]
5. Accelerated protein turnover in the skeletal muscle of dystrophic mice.
Mizobuchi M; Inoue R; Miyaka M; Kakimoto Y
Biochim Biophys Acta; 1985 Nov; 843(1-2):78-82. PubMed ID: 3933571
[TBL] [Abstract][Full Text] [Related]
6. Abnormal distribution of proteins in the soleus and extensor digitorum longus of dystrophic mice.
Jasch LG; Bressler BH; Ovalle WK; Slonecker CE
Muscle Nerve; 1982; 5(6):462-70. PubMed ID: 7133042
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of chymostatin on dystrophic mice.
Komatsu K; Matsui A; Satoh S
Exp Neurol; 1986 Jul; 93(1):110-6. PubMed ID: 3732454
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
